Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-25 @ 9:25 PM
Study NCT ID:
NCT06234956
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2023-10-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.
Sponsor:
Hipra Scientific, S.L.U
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2023-10-20
First Submit QC Date:
None
Study First Post Date:
2024-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED